Stephanie Wesolowski
Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetus | 30 | 2023 | 702 | 4.220 |
Why?
| Sheep | 40 | 2023 | 764 | 4.040 |
Why?
| Glucose | 22 | 2023 | 900 | 3.550 |
Why?
| Liver | 23 | 2021 | 1681 | 3.540 |
Why?
| Fetal Growth Retardation | 24 | 2023 | 466 | 3.240 |
Why?
| Placental Insufficiency | 14 | 2023 | 102 | 2.500 |
Why?
| Insulin | 28 | 2023 | 2083 | 2.370 |
Why?
| Amino Acids | 14 | 2023 | 451 | 2.060 |
Why?
| Pregnancy | 55 | 2023 | 5520 | 1.880 |
Why?
| Diet, Western | 9 | 2023 | 66 | 1.850 |
Why?
| Non-alcoholic Fatty Liver Disease | 4 | 2023 | 246 | 1.650 |
Why?
| Muscle, Skeletal | 17 | 2023 | 1477 | 1.540 |
Why?
| Hypoxia | 5 | 2021 | 959 | 1.530 |
Why?
| Gluconeogenesis | 7 | 2019 | 62 | 1.320 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2021 | 141 | 1.260 |
Why?
| Insulin Resistance | 10 | 2023 | 1077 | 1.230 |
Why?
| Animals | 70 | 2023 | 31868 | 1.110 |
Why?
| Lactic Acid | 4 | 2023 | 278 | 1.110 |
Why?
| Fetal Development | 10 | 2022 | 247 | 1.090 |
Why?
| Pancreas | 6 | 2021 | 280 | 1.090 |
Why?
| Prenatal Exposure Delayed Effects | 4 | 2018 | 450 | 1.070 |
Why?
| Hyperinsulinism | 4 | 2020 | 103 | 1.070 |
Why?
| Placental Circulation | 4 | 2022 | 56 | 1.060 |
Why?
| Fetal Hypoxia | 3 | 2021 | 47 | 1.020 |
Why?
| Maternal-Fetal Exchange | 4 | 2021 | 151 | 0.870 |
Why?
| Leucine | 7 | 2022 | 107 | 0.840 |
Why?
| Glucose Clamp Technique | 4 | 2020 | 181 | 0.820 |
Why?
| Adipose Tissue | 5 | 2021 | 558 | 0.820 |
Why?
| Adaptation, Physiological | 3 | 2021 | 481 | 0.770 |
Why?
| Female | 67 | 2023 | 59619 | 0.750 |
Why?
| Metformin | 1 | 2023 | 278 | 0.690 |
Why?
| Liver Cirrhosis | 1 | 2021 | 235 | 0.690 |
Why?
| Islets of Langerhans | 6 | 2023 | 729 | 0.620 |
Why?
| Pregnancy Complications | 2 | 2019 | 430 | 0.590 |
Why?
| Leptin | 5 | 2016 | 211 | 0.570 |
Why?
| Blood Glucose | 8 | 2021 | 1822 | 0.560 |
Why?
| Oxygen | 7 | 2023 | 854 | 0.550 |
Why?
| Placenta | 7 | 2023 | 624 | 0.530 |
Why?
| Disease Models, Animal | 9 | 2021 | 3545 | 0.500 |
Why?
| Gestational Age | 6 | 2021 | 758 | 0.500 |
Why?
| Lactation | 3 | 2016 | 149 | 0.490 |
Why?
| Primates | 4 | 2023 | 111 | 0.480 |
Why?
| Energy Metabolism | 2 | 2021 | 729 | 0.480 |
Why?
| Oxidation-Reduction | 6 | 2021 | 926 | 0.480 |
Why?
| Obesity | 6 | 2018 | 2524 | 0.450 |
Why?
| Hepatocytes | 4 | 2023 | 196 | 0.450 |
Why?
| Myoblasts | 3 | 2021 | 77 | 0.440 |
Why?
| Mammary Glands, Animal | 3 | 2010 | 116 | 0.440 |
Why?
| Insulin-Secreting Cells | 3 | 2018 | 318 | 0.430 |
Why?
| Insulin-Like Growth Factor I | 5 | 2021 | 286 | 0.420 |
Why?
| AMP-Activated Protein Kinases | 2 | 2023 | 175 | 0.400 |
Why?
| Lipid Metabolism | 5 | 2023 | 449 | 0.390 |
Why?
| Uterus | 3 | 2021 | 192 | 0.390 |
Why?
| Fetal Blood | 4 | 2021 | 270 | 0.390 |
Why?
| RNA, Messenger | 8 | 2016 | 2563 | 0.390 |
Why?
| Diet, High-Fat | 3 | 2023 | 225 | 0.360 |
Why?
| Macaca | 5 | 2018 | 50 | 0.360 |
Why?
| Infusions, Intravenous | 6 | 2021 | 372 | 0.340 |
Why?
| Receptors, Leptin | 3 | 2008 | 24 | 0.340 |
Why?
| Gene Expression Regulation | 6 | 2020 | 2329 | 0.320 |
Why?
| Cattle | 5 | 2016 | 924 | 0.320 |
Why?
| Up-Regulation | 4 | 2017 | 812 | 0.280 |
Why?
| Gene Expression Profiling | 3 | 2019 | 1523 | 0.270 |
Why?
| Hypoglycemia | 3 | 2014 | 386 | 0.270 |
Why?
| Mitochondria | 2 | 2021 | 750 | 0.260 |
Why?
| Glucagon | 4 | 2021 | 93 | 0.260 |
Why?
| Muscle Development | 3 | 2021 | 98 | 0.260 |
Why?
| Muscle Fibers, Skeletal | 3 | 2021 | 185 | 0.250 |
Why?
| Cell Proliferation | 4 | 2021 | 2191 | 0.250 |
Why?
| Sheep, Domestic | 3 | 2019 | 33 | 0.250 |
Why?
| Linoleic Acids, Conjugated | 1 | 2014 | 5 | 0.240 |
Why?
| Fatty Acids | 2 | 2023 | 385 | 0.240 |
Why?
| Mammals | 2 | 2023 | 245 | 0.240 |
Why?
| Glycine | 2 | 2023 | 153 | 0.230 |
Why?
| Signal Transduction | 6 | 2020 | 4525 | 0.230 |
Why?
| Oxidative Stress | 2 | 2021 | 1085 | 0.230 |
Why?
| Macrophages | 3 | 2020 | 1267 | 0.230 |
Why?
| Stilbenes | 1 | 2014 | 36 | 0.230 |
Why?
| Hindlimb | 3 | 2021 | 130 | 0.230 |
Why?
| Milk | 1 | 2014 | 124 | 0.220 |
Why?
| Pyruvates | 1 | 2023 | 20 | 0.220 |
Why?
| Muscle Proteins | 3 | 2022 | 210 | 0.210 |
Why?
| Glutamine | 1 | 2023 | 91 | 0.210 |
Why?
| Body Temperature Regulation | 1 | 2003 | 72 | 0.210 |
Why?
| Serine | 1 | 2023 | 126 | 0.210 |
Why?
| Citric Acid Cycle | 2 | 2021 | 43 | 0.210 |
Why?
| Blotting, Western | 3 | 2019 | 1149 | 0.200 |
Why?
| Hypothalamus | 1 | 2003 | 147 | 0.200 |
Why?
| Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 15 | 0.200 |
Why?
| Dietary Fats | 1 | 2014 | 290 | 0.200 |
Why?
| Gene Expression | 4 | 2023 | 1423 | 0.200 |
Why?
| Malnutrition | 1 | 2012 | 61 | 0.200 |
Why?
| Myoblasts, Skeletal | 1 | 2021 | 11 | 0.200 |
Why?
| Citrate (si)-Synthase | 1 | 2021 | 46 | 0.200 |
Why?
| Quantitative Trait Loci | 1 | 2004 | 309 | 0.200 |
Why?
| Fatty Liver | 1 | 2014 | 217 | 0.200 |
Why?
| Bone Marrow | 1 | 2023 | 247 | 0.190 |
Why?
| Sympathetic Nervous System | 1 | 2012 | 171 | 0.190 |
Why?
| Pyruvic Acid | 1 | 2021 | 42 | 0.190 |
Why?
| Swine | 1 | 2004 | 704 | 0.190 |
Why?
| Gene Expression Regulation, Developmental | 3 | 2019 | 799 | 0.190 |
Why?
| Phenotype | 3 | 2023 | 2815 | 0.190 |
Why?
| Triglycerides | 2 | 2018 | 471 | 0.180 |
Why?
| Mitochondrial Diseases | 1 | 2021 | 77 | 0.180 |
Why?
| Fibrosis | 1 | 2023 | 454 | 0.180 |
Why?
| Maternal Exposure | 1 | 2021 | 138 | 0.180 |
Why?
| Mitochondria, Liver | 1 | 2020 | 66 | 0.180 |
Why?
| Glycolysis | 1 | 2021 | 227 | 0.180 |
Why?
| Diabetes Mellitus, Type 2 | 3 | 2023 | 2098 | 0.170 |
Why?
| Hematopoietic Stem Cells | 1 | 2023 | 344 | 0.170 |
Why?
| Chorioamnionitis | 1 | 2020 | 36 | 0.170 |
Why?
| Protein Biosynthesis | 2 | 2017 | 389 | 0.170 |
Why?
| Organ Size | 4 | 2021 | 444 | 0.170 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 928 | 0.170 |
Why?
| Sexual Maturation | 2 | 2008 | 47 | 0.170 |
Why?
| Acidosis | 1 | 2020 | 87 | 0.160 |
Why?
| Genomics | 1 | 2004 | 641 | 0.160 |
Why?
| Antioxidants | 1 | 2023 | 530 | 0.160 |
Why?
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.160 |
Why?
| Drug Administration Schedule | 4 | 2021 | 719 | 0.160 |
Why?
| STAT3 Transcription Factor | 1 | 2010 | 174 | 0.160 |
Why?
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 32 | 0.150 |
Why?
| Embryo, Mammalian | 1 | 2019 | 214 | 0.150 |
Why?
| Stem Cells | 1 | 2022 | 546 | 0.150 |
Why?
| Anemia | 2 | 2017 | 144 | 0.150 |
Why?
| Cytokines | 3 | 2014 | 1843 | 0.150 |
Why?
| Estradiol | 2 | 2010 | 455 | 0.150 |
Why?
| Cell Division | 2 | 2017 | 758 | 0.150 |
Why?
| Oxygen Consumption | 1 | 2020 | 588 | 0.150 |
Why?
| Hypoglycemic Agents | 2 | 2021 | 1008 | 0.150 |
Why?
| Metabolic Diseases | 1 | 2018 | 98 | 0.150 |
Why?
| Glucose Intolerance | 1 | 2018 | 137 | 0.140 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 127 | 0.140 |
Why?
| Adiponectin | 1 | 2018 | 212 | 0.140 |
Why?
| Hydrocortisone | 4 | 2020 | 267 | 0.140 |
Why?
| Prenatal Nutritional Physiological Phenomena | 1 | 2016 | 57 | 0.130 |
Why?
| Proteins | 1 | 2012 | 915 | 0.130 |
Why?
| Male | 12 | 2023 | 55737 | 0.130 |
Why?
| Random Allocation | 3 | 2012 | 336 | 0.130 |
Why?
| Lower Extremity | 1 | 2019 | 337 | 0.130 |
Why?
| Lactates | 1 | 2015 | 84 | 0.130 |
Why?
| Glucose-6-Phosphatase | 3 | 2016 | 31 | 0.120 |
Why?
| Hyperglycemia | 1 | 2018 | 293 | 0.120 |
Why?
| Transcription Factors | 2 | 2014 | 1531 | 0.120 |
Why?
| Endocrine System Diseases | 1 | 2014 | 30 | 0.120 |
Why?
| Epithelial Cells | 2 | 2008 | 956 | 0.110 |
Why?
| Humans | 14 | 2023 | 115052 | 0.110 |
Why?
| Growth Hormone | 3 | 2016 | 103 | 0.110 |
Why?
| Inflammation | 2 | 2020 | 2485 | 0.110 |
Why?
| Transcriptome | 1 | 2019 | 726 | 0.110 |
Why?
| Blotting, Northern | 2 | 2004 | 193 | 0.110 |
Why?
| Breast Feeding | 1 | 2016 | 367 | 0.110 |
Why?
| Animal Feed | 2 | 2021 | 49 | 0.100 |
Why?
| Biomarkers | 2 | 2021 | 3419 | 0.100 |
Why?
| Epigenesis, Genetic | 1 | 2016 | 524 | 0.100 |
Why?
| Chromosome Mapping | 2 | 2004 | 490 | 0.100 |
Why?
| Mice | 6 | 2022 | 14928 | 0.100 |
Why?
| Fetal Weight | 2 | 2021 | 52 | 0.100 |
Why?
| Oxidative Phosphorylation | 2 | 2021 | 156 | 0.090 |
Why?
| Polymerase Chain Reaction | 2 | 2004 | 999 | 0.090 |
Why?
| Infant, Newborn | 2 | 2021 | 5040 | 0.090 |
Why?
| Gastrointestinal Microbiome | 1 | 2016 | 502 | 0.090 |
Why?
| Glycogen | 2 | 2016 | 51 | 0.090 |
Why?
| Phosphorylation | 3 | 2020 | 1572 | 0.080 |
Why?
| Mice, Obese | 2 | 2018 | 54 | 0.080 |
Why?
| Tissue Distribution | 2 | 2012 | 286 | 0.080 |
Why?
| Dietary Supplements | 2 | 2014 | 458 | 0.080 |
Why?
| Models, Animal | 2 | 2016 | 348 | 0.080 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 400 | 0.080 |
Why?
| Inflammation Mediators | 2 | 2012 | 476 | 0.080 |
Why?
| Amino Acids, Branched-Chain | 2 | 2012 | 32 | 0.070 |
Why?
| Down-Regulation | 2 | 2017 | 599 | 0.070 |
Why?
| Animal Nutritional Physiological Phenomena | 2 | 2008 | 12 | 0.070 |
Why?
| Liver Glycogen | 2 | 2016 | 19 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2017 | 1857 | 0.070 |
Why?
| Biological Transport | 2 | 2020 | 372 | 0.070 |
Why?
| Immunity, Innate | 2 | 2023 | 723 | 0.070 |
Why?
| RNA | 2 | 2008 | 810 | 0.060 |
Why?
| Lactalbumin | 1 | 2014 | 2 | 0.060 |
Why?
| Fatty Acid Synthases | 1 | 2014 | 23 | 0.060 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 54 | 0.060 |
Why?
| Milk Proteins | 1 | 2014 | 36 | 0.060 |
Why?
| Lipogenesis | 1 | 2014 | 57 | 0.060 |
Why?
| Contraindications | 1 | 2014 | 86 | 0.060 |
Why?
| Gene Order | 1 | 2003 | 24 | 0.050 |
Why?
| Risk Factors | 1 | 2016 | 8642 | 0.050 |
Why?
| Expressed Sequence Tags | 1 | 2003 | 38 | 0.050 |
Why?
| Ceramides | 1 | 2023 | 94 | 0.050 |
Why?
| Animals, Inbred Strains | 1 | 2012 | 7 | 0.050 |
Why?
| Computer Systems | 1 | 2003 | 46 | 0.050 |
Why?
| Macrophage Activation | 1 | 2014 | 164 | 0.050 |
Why?
| Receptors, Neuropeptide Y | 1 | 2012 | 1 | 0.050 |
Why?
| Sympathetic Fibers, Postganglionic | 1 | 2012 | 4 | 0.050 |
Why?
| Neuropeptide Y | 1 | 2012 | 13 | 0.050 |
Why?
| Glucose Transporter Type 2 | 1 | 2012 | 10 | 0.050 |
Why?
| Glucose Tolerance Test | 1 | 2014 | 344 | 0.050 |
Why?
| Electrolytes | 1 | 2012 | 55 | 0.050 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2012 | 68 | 0.050 |
Why?
| Cell Size | 1 | 2012 | 81 | 0.050 |
Why?
| Glucagon-Secreting Cells | 1 | 2012 | 20 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2018 | 4718 | 0.050 |
Why?
| Hepatitis | 1 | 2012 | 45 | 0.050 |
Why?
| Solutions | 1 | 2012 | 148 | 0.050 |
Why?
| Mice, Inbred Strains | 1 | 2003 | 398 | 0.050 |
Why?
| Macaca mulatta | 1 | 2022 | 131 | 0.050 |
Why?
| Genetic Predisposition to Disease | 2 | 2016 | 2108 | 0.050 |
Why?
| Apoptosis | 2 | 2019 | 2366 | 0.050 |
Why?
| Acid-Base Equilibrium | 1 | 2012 | 30 | 0.050 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 144 | 0.050 |
Why?
| Regional Blood Flow | 1 | 2014 | 428 | 0.050 |
Why?
| Blood Gas Analysis | 1 | 2012 | 74 | 0.050 |
Why?
| Time Factors | 2 | 2012 | 6142 | 0.050 |
Why?
| Pulmonary Gas Exchange | 1 | 2012 | 117 | 0.050 |
Why?
| Carbon Isotopes | 1 | 2012 | 112 | 0.050 |
Why?
| Uterine Artery | 1 | 2022 | 67 | 0.050 |
Why?
| Mice, SCID | 1 | 2022 | 319 | 0.050 |
Why?
| Proteolysis | 1 | 2012 | 143 | 0.050 |
Why?
| Forkhead Transcription Factors | 1 | 2012 | 171 | 0.050 |
Why?
| Arginine | 1 | 2012 | 238 | 0.050 |
Why?
| Hormones | 1 | 2012 | 132 | 0.050 |
Why?
| Infusion Pumps | 1 | 2021 | 31 | 0.050 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 315 | 0.050 |
Why?
| Placentation | 1 | 2021 | 40 | 0.050 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 744 | 0.050 |
Why?
| Mice, Inbred NOD | 1 | 2022 | 559 | 0.050 |
Why?
| Fetal Macrosomia | 1 | 2021 | 58 | 0.050 |
Why?
| Pancreatic Diseases | 1 | 2021 | 64 | 0.050 |
Why?
| Carbon Dioxide | 1 | 2012 | 218 | 0.040 |
Why?
| Receptors, Nicotinic | 1 | 2012 | 275 | 0.040 |
Why?
| Nuclear Proteins | 1 | 2014 | 593 | 0.040 |
Why?
| Drug Synergism | 1 | 2020 | 317 | 0.040 |
Why?
| Fetal Diseases | 1 | 2021 | 148 | 0.040 |
Why?
| Bromodeoxyuridine | 1 | 2019 | 72 | 0.040 |
Why?
| Body Weight | 1 | 2004 | 873 | 0.040 |
Why?
| Pregnancy, Animal | 1 | 2019 | 52 | 0.040 |
Why?
| Norepinephrine | 1 | 2020 | 208 | 0.040 |
Why?
| Alanine | 1 | 2019 | 104 | 0.040 |
Why?
| Kinetics | 1 | 2012 | 1558 | 0.040 |
Why?
| Molecular Sequence Data | 1 | 2003 | 2796 | 0.040 |
Why?
| Oncogene Protein v-akt | 1 | 2007 | 26 | 0.040 |
Why?
| Cell Line, Transformed | 1 | 2008 | 133 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2004 | 1317 | 0.040 |
Why?
| Chemokine CCL2 | 1 | 2008 | 105 | 0.040 |
Why?
| Dairying | 1 | 2007 | 7 | 0.040 |
Why?
| Cell Count | 1 | 2018 | 304 | 0.040 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 83 | 0.040 |
Why?
| Receptor, Insulin | 1 | 2007 | 93 | 0.040 |
Why?
| Caloric Restriction | 1 | 2008 | 90 | 0.040 |
Why?
| Injections, Subcutaneous | 1 | 2007 | 133 | 0.040 |
Why?
| Temperature | 1 | 2019 | 578 | 0.040 |
Why?
| Diabetes, Gestational | 1 | 2021 | 281 | 0.040 |
Why?
| Ovariectomy | 1 | 2007 | 117 | 0.040 |
Why?
| Lipopolysaccharides | 1 | 2020 | 817 | 0.030 |
Why?
| Diet | 1 | 2014 | 1076 | 0.030 |
Why?
| Apolipoproteins B | 1 | 2016 | 41 | 0.030 |
Why?
| Cloning, Molecular | 1 | 2007 | 524 | 0.030 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2006 | 17 | 0.030 |
Why?
| Animals, Newborn | 1 | 2018 | 778 | 0.030 |
Why?
| Thyroid Hormones | 1 | 2016 | 53 | 0.030 |
Why?
| Umbilical Cord | 1 | 2016 | 80 | 0.030 |
Why?
| Exons | 1 | 2016 | 301 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2008 | 370 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2008 | 448 | 0.030 |
Why?
| Luteinizing Hormone | 1 | 2016 | 169 | 0.030 |
Why?
| Mice, Transgenic | 1 | 2010 | 1955 | 0.030 |
Why?
| Carbon Radioisotopes | 1 | 2014 | 38 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2016 | 344 | 0.030 |
Why?
| Genome | 1 | 2016 | 271 | 0.030 |
Why?
| Receptors, Cell Surface | 1 | 2006 | 354 | 0.030 |
Why?
| In Vitro Techniques | 1 | 2016 | 1036 | 0.030 |
Why?
| Interleukin-6 | 1 | 2008 | 676 | 0.030 |
Why?
| Blood Transfusion | 1 | 2016 | 276 | 0.030 |
Why?
| Eating | 1 | 2016 | 347 | 0.030 |
Why?
| Glutamic Acid | 1 | 2014 | 211 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2008 | 1138 | 0.030 |
Why?
| Cells, Cultured | 1 | 2010 | 3896 | 0.030 |
Why?
| Genetic Variation | 1 | 2016 | 876 | 0.020 |
Why?
| Genotype | 1 | 2016 | 1780 | 0.020 |
Why?
| Erythrocytes | 1 | 2016 | 591 | 0.020 |
Why?
| Chronic Disease | 1 | 2017 | 1591 | 0.020 |
Why?
| Cell Line | 1 | 2006 | 2645 | 0.020 |
Why?
| Adenylate Kinase | 1 | 2009 | 27 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2016 | 1901 | 0.020 |
Why?
| Peptide Chain Initiation, Translational | 1 | 2009 | 38 | 0.020 |
Why?
| Algorithms | 1 | 2014 | 1489 | 0.020 |
Why?
| Adolescent | 1 | 2023 | 17866 | 0.020 |
Why?
| Adult | 1 | 2011 | 30658 | 0.010 |
Why?
|
|
Wesolowski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|